(Q48772031)

15 February 2018

title

Identification of EGFRvIII-derived CTL epitopes restricted by HLA A0201 for dendritic cell based immunotherapy of gliomas. (English)

1 reference

15 February 2018

1 reference

1 reference

An-hua Wu

1

1 reference

15 February 2018

Jing Xiao

2

1 reference

15 February 2018

Lars Anker

3

1 reference

15 February 2018

Walter A Hall

4

1 reference

15 February 2018

Dale S Gregerson

5

1 reference

15 February 2018

Webster K Cavenee

6

1 reference

15 February 2018

Wei Chen

7

1 reference

15 February 2018

Walter C Low

8

1 reference

15 February 2018

publication date

1 January 2006

1 reference

15 February 2018

Journal of Neuro-Oncology

published in

1 reference

15 February 2018

volume

76

1 reference

15 February 2018

issue

1

1 reference

15 February 2018

page(s)

23-30

1 reference

15 February 2018

https://scigraph.springernature.com/pub.10.1007/s11060-005-3280-7

exact match

0 references

cites work

Immune responses to the HLA-A*0201-restricted epitopes of tyrosinase and glycoprotein 100 enable control of melanoma outgrowth in HLA-A*0201-transgenic mice.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-005-3280-7

Functional analysis of tumor-specific Th cell responses detected in melanoma patients after dendritic cell-based immunotherapy

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-005-3280-7

CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis

21 January 2018

1 reference

12 December 2020

Dendritic cells: specialized and regulated antigen processing machines

1 reference

12 December 2020

Glioma immunology and immunotherapy.

1 reference

12 December 2020

Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine

1 reference

12 December 2020

Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens

1 reference

12 December 2020

Dendritic cells pulsed with CEA peptide induce CEA-specific CTL with restricted TCR repertoire.

1 reference

12 December 2020

Apoptotic elimination of peripheral T lymphocytes in patients with primary intracranial tumors.

1 reference

12 December 2020

Immunity to Oncogenic Proteins

1 reference

12 December 2020

Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration

1 reference

12 December 2020

Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts.

1 reference

12 December 2020

Proliferating dendritic cell progenitors in human blood

1 reference

12 December 2020

Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas.

1 reference

12 December 2020

T cell recognition of transforming proteins encoded by mutated ras proto-oncogenes

1 reference

12 December 2020

EGF mutant receptor vIII as a molecular target in cancer therapy

1 reference

12 December 2020

CD4+ T-cell immunity to mutated ras protein in pancreatic and colon cancer patients

1 reference

12 December 2020

Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells.

1 reference

12 December 2020

Enhancement of cytolytic T lymphocyte precursor frequency in melanoma patients following immunization with the MAGE-1 peptide loaded antigen presenting cell-based vaccine

1 reference

12 December 2020

Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines

1 reference

12 December 2020

Design of a flow cytometric assay for the determination of natural killer and cytotoxic T-lymphocyte activity in human and in different animal species

1 reference

12 December 2020

Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2)

1 reference

12 December 2020

The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling

1 reference

12 December 2020

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

1 reference

12 December 2020

Lysis of ras oncogene-transformed cells by specific cytotoxic T lymphocytes elicited by primary in vitro immunization with mutated ras peptide

1 reference

12 December 2020

Dendritic Cells Pulsed with a Tumor-specific Peptide Induce Long-lasting Immunity and Are Effective against Murine Intracerebral Melanoma

1 reference

12 December 2020

HLA-B35-restricted immune responses against survivin in cancer patients

1 reference

12 December 2020

Identification of HLA a*0201 glioblastoma multiforme cell lines for immunotherapy by PCR-SSP and DNA sequencing

1 reference

12 December 2020

Use of two predictive algorithms of the world wide web for the identification of tumor-reactive T-cell epitopes.

1 reference

12 December 2020

Epidermal growth factor receptor VIII peptide vaccination is efficacious against established intracerebral tumors

1 reference

12 December 2020

T-cell immunity to the joining region of p210BCR-ABL protein

1 reference

12 December 2020

Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides

1 reference

12 December 2020

The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target.

1 reference

12 December 2020

The first 1000 dendritic cell vaccinees.

1 reference

12 December 2020

A naturally occurring mutant human epidermal growth factor receptor as a target for peptide vaccine immunotherapy of tumors

1 reference

12 December 2020

Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial

1 reference

12 December 2020

Immunization with dendritic cells pulsed with tumor extract increases survival of mice bearing intracranial gliomas

1 reference

12 December 2020

T cells activated in vitro as immunotherapy for renal cell carcinoma: characterization of 2 effector T-cell populations

1 reference

12 December 2020

Induction of systemic CTL responses in melanoma patients by dendritic cell vaccination: cessation of CTL responses is associated with disease progression.

1 reference

12 December 2020

Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer.

1 reference

12 December 2020

In vitro induction of a bladder cancer-specific T-cell response by mRNA-transfected dendritic cells

1 reference

12 December 2020

10.1007/S11060-005-3280-7

Identifiers

DOI

1 reference

15 February 2018

PubMed ID

16155724

1 reference

15 February 2018